Specifically, patients with SSc-ILD+ showed higher levels of MMP-1 and lower levels of MMP-12 in relation to patients with IPF (p = 0.0201 and p = 0.0327, respectively, Fig. 2B). This evidence concerns the gene MMP12 and systemic sclerosis.